Stevens–Johnson syndrome induced by toripalimab in a previously EGFR-TKI-treated advanced lung adenocarcinoma patient harboring EGFR mutations 19 del/T790M/C797S in trans and cis: a case report

Background: The treatment paradigm for advanced non-small-cell lung cancer (NSCLC) is rapidly changing. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and anti-programmed death-1 (PD-1) antibodies have increasingly been incorporated into routine care for nearly all patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yang, Hong, Hanhan, Bao, Shujun, Tang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682071/
https://www.ncbi.nlm.nih.gov/pubmed/38035001
http://dx.doi.org/10.3389/fphar.2023.1131703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682071/
https://www.ncbi.nlm.nih.gov/pubmed/38035001
http://dx.doi.org/10.3389/fphar.2023.1131703

Ejemplares similares